Bone marrow microenvironment: culprit and target
Bone marrow microenvironment: culprit and target
PD-1 inhibition and (Non-)Hodgkin lymphoma: promising outcomes in an emerging field
PD-1 inhibition and (Non-)Hodgkin lymphoma: prom
Finding the way among a multitude of targets and regimens
Finding the way among a multitude of targets and
Advancing treatment in patients with mantle cell lymphoma
Advancing treatment in patients with mantle cell
Approaching marginal zone lymphoma from various angles
Approaching marginal zone lymphoma from various
Insights from early clinical trials on targeted treatment in B-cell malignancies
Insights from early clinical trials on targeted
Management of CLL patients: BTK inhibition and beyond
Management of CLL patients: BTK inhibition and b
What is new in Waldenström’s macroglobulinemia?
What is new in Waldenström’s macroglobulinemia?
Preface – ASH 2020
Preface – ASH 2020 Heinz Ludwig, MD, Direc
